What Do You Think?

[LadyROOT]

I have know for years that the U.S. health care system and companies are usually more worried about money than the actual health of the people they are suppose to be serving/protecting. But when an alleged cure / prevention causes health problems in nearly as many people as the health issue they are trying to prevent one really has to wonder just what is going on with the U.S. government as well as the World Health Organization since this treatment is being given/sold in many countries around the world including lower status/income countries. I really wonder if this “cure” is about helping people, making money, or simply a government approved global experiment to do who knows what?

I am going to post some old and new articles about the HPV Vaccine. If theses reports are even half way accurate it seems fairly clear that the distribution of this “vaccine” has never been about helping people or even remotely in the best interest of those that are forced to take it.

[LadyROOT]

there are many reference links in this article it is worth going to the main page to read the collaborating information.

copied from:
http://www.naturalnews.com/024234_HPV_vaccine.html



U.S. Government Mandates HPV Vaccine For New US Residents

Wednesday, September 17, 2008 by: Sherry Baker, Health Sciences Editor


(NaturalNews) Despite growing reports of serious and even fatal reactions to the human papillomavirus ( HPV) vaccine, the U.S. Citizenship and Immigration Services (USCIS) announced today that people from other countries who want to become legal permanent residents of the US are required to have the HPV vaccination to protect against cervical cancer.

The new rule, outlined in the Centers for Disease Control's (CDC) revised Technical Instructions to Civil Surgeons for Vaccination Requirements , stipulates "age-appropriate" groups, which means girls and young adult women , have to show proof of the vaccinations or they will not be granted legal permanent resident status in the U.S.

This marks another enormous marketing success for the drug giant Merck & Co., maker of the HPV vaccine,Gardasil . Merck has lobbied for virtual universal vaccination of females with the vaccine. Gadisil is currently licensed in for use in girls and women ages 9 to 26 and many health and school officials are pushing to make the vaccine mandatory for all girls by the age of 11 or 12. Some doctors are also offering Gardasil "off label" to women in their 20s to "catch-up" on their vaccinations. Merck, whose profits from the vaccine are expected to be in the billions , also wants to market it to women ages 27 to 45. So far the U.S. Food and Drug Administration has denied that request .

The rationale for the current push in this country as well as in Europe to immunize against the HPV virus is the claim it protects women from developing HPV-caused genital warts and , most importantly, cervical cancer ( and other even more rare malignancies of the female reproductive tract).However, a look at the statistics -- and risks associated with taking the vaccine – raise some common sense questions about both the safety and efficacy of Gardasil.

For example, American Cancer Society estimates that in 2008, 11,070 women will be diagnosed with cervical cancer in this country. With early detection, cervical cancer is highly treatable and curable. But the HPV vaccine, Gardasil, has only been on the market since 2006 and has already been responsible for thousands of documented severe side effects, including numerous deaths.

Judicial Watch, a public interest group, says the most recent reports show the vaccine has caused 21 deaths and 9,749 adverse reactions, including 78 outbreaks of the genital warts it is supposed to protect against, as well as 10 miscarriages.

And this may be the tip of the serious side effect iceberg when it comes to Gardasil: A study published in the New England Journal of Medicine concludes only about 10% of actual side effects end up being reported to the Vaccine Adverse Event Reporting System (VAERS).

There is mounting evidence Gardasil isn't even particularly effective. The European Union, which, like the US government, is actively pushing for massive Gardasil vaccinations ,admits on its consumer health web site that "HPV vaccination is not a replacement for routine cervical screening.. no vaccine is 100% effective and HPV vaccines will not provide protection against non-vaccine HPV types, or against existing HPV infections.."

HPV is one of the most common sexually transmitted diseases (STDs) and close to 90 percent of all people who have sex get HPV at some point in their lives. The more sexual partners you have, the more likely you will contract a form of the infection.Six million Americans are infected with HPV every year but only a tiny percentage actually develop serious problems.

There are numerous strains of HPV yet only a few are linked to cancer. What's more, only about 10 percent of women who do contract the high-risk types of HPV on their cervix will develop long-lasting HPV infections that put them at risk for cervical cancer, according to the CDC's own web site.
The site also states: "Most infections with high-risk HPV types do not lead to cancer. The immune system can often remove the virus before it causes problems. ..In most cases, the body fights off HPV naturally and the infected cells then go back to normal." The CDC experts also point out that people with HPV caused warts can use patient-applied creams to treat them – or just wait until they go away on their own.

Bottom line: A non-promiscuous lifestyle and a healthy immune system offer the best ways to guard against HPV and HPV-caused cancer.

Unfortunately, the new U.S. Citizenship and Immigration Services ruling demanding HPV vaccinations of new permanent legal permanent residents of this country is another worrisome step toward government mandated vaccinations that reduce individual health choice and freedom.

[LadyROOT]

http://www.naturalnews.com/025613_cancer_HPV_vaccine.html


The Tragic Truth behind the Gardasil Nightmare

Friday, February 13, 2009 by: Herb Newborg

Learn more: http://www.naturalnews.com/025613_cancer_HPV_vaccine.html#ixzz1aQ9shfui


(NaturalNews) Why have the pharmaceutical and biotechnology industries chosen to experiment with the first ever, large scale application of a new, unproven, genetically modified, inter-species gene mixing vaccine technology on the female youth of an entire generation?

Under the ruse of attempting to eradicate cervical cancer, Merck is actually engaged in the first large scale, real world deployment and testing of genetically modified DNA, genetically engineered proteins and genetics produced by the combining of genetic material from more than one origin or species in a vaccine.

The wide spread promotion and attempts to mandate the use of this drug in the United States is clearly not predicated on preventing deaths from cervical cancer as the drug has only been approved in the U.S. for use in girls 9-26, ages when deaths from cervical cancer happen rarely, if ever. Cervical cancer has been steadily decreasing in the U.S. since 1955.

The American Cancer Society states:

"Cervical cancer was once one of the most common causes of cancer death for American women. The cervical cancer death rate declined by 74% between 1955 and 1992. The main reason for this change is the increased use of the Pap test. This screening procedure can find changes in the cervix before cancer develops. It can also find early cervical cancer in its most curable stage. The death rate from cervical cancer continues to decline by nearly 4% a year. Cervical cancer tends to occur in midlife. Most cases are found in women younger than 50. It rarely develops in women younger than 20. Almost 20 percent of women are diagnosed with cervical cancer when they are over 65."

According to a 2001 presentation by Elizabeth R. Unger Ph.D., M.D., then Acting Chief, Papillomavirus Section of the U.S. Centers for Disease Control and Prevention (CDCP):
*HPV infection is very prevalent in the population
*OVERALL 75% of population exposed
*Genital HPV is acquired around the time of sexual debut
*Consistent epidemiologic association of HPV with cervical cancer precursor lesions
*Plausible biologic mechanisms for HPV oncogenesis (cells becoming cancerous)
*HPV oncogenesis is a rare event with long interval between infection and cancer
*Infection alone is insufficient to cause cancer
*Additional factors required for neoplasia (abnormal proliferation of cells)

Paraphrasing, more than 75% of the population is exposed to HPV. HPV exposure typically occurs when a woman becomes sexually active. There is an association between HPV and cervical cancer. HPV causing cervical cancer is plausible, yet it alone does not cause cervical cancer. Cervical cancer is a rare event and there is a "long interval" between infection and development of cervical cancer.

Now follow closely. Cervical cancer typically develops in mid life (around 48 years old) even though HPV exposure typically occurs at sexual debut. This new vaccine is purported to protect against a disease that occurs, if ever, 20 to 35 years after HPV infection. Yet the duration of protection from the vaccine is unknown.

According to the FDA Gardasil approval announcement: "For most women, the body`s own defense system will clear the virus and infected women do not develop related health problems. However, some HPV types can cause abnormal cells on the lining of the cervix that years later can turn into cancer."

The clinical trials on this vaccine only lasted 5 years. It is chronologically impossible to have determined efficacy in preventing cervical cancer as a result of administration of this vaccine in the study population. Speculation as to whether the protection against HPV offered by this vaccine lasts beyond the five years of studies conducted to date is just that, speculation.

By the FDA`s own statement: "For most women, the body`s own defense system will clear the virus". Combined with the frequent Pap tests of study participants who were participating in a study of sexually transmitted disease, it is fair to say that the 20,541 sixteen to twenty-six year old participants in the clinical trials were far from a random representation of the average female`s risk for contracting HPV or developing cervical cancer.

The studies on nine to fifteen year old girls included far fewer participants and were halted prior to completion.

Speculation as to whether or not girls vaccinated with Gardasil will experience a lower rate of cervical cancer 10 to 30 years from now is also merely conjecture. As such, there is currently no official schedule on required booster doses of the drug.

In the FDA`s approval announcement, they state: "While the study period was not long enough for cervical cancer to develop, the prevention of these cervical precancerous lesions is believed highly likely to result in the prevention of those cancers."

Believed highly likely?

Is the role of the FDA to ensure that a drug has been proven to be a safe and effective or have we reduced the burden down to "likely to convey some benefit, maybe, sometime down the road"?

In addition, according to the FDA announcement of Gardasil`s approval , somehow the association and plausible mechanism between HPV and cervical cancer with the crystal clear statement that HPV "infection alone is insufficient to cause cancer" stated in the 2001 CDCP presentation magically morphed into "HPV is the cause of 70% of all cervical cancer".

Promoting a new, unproven, vaccine to an entire generation of young girls as a cancer vaccine, without adequate long-term safety or efficacy testing is unethical and in this author`s opinion immoral.

But wait, there is much more.

This is a whole new type of vaccine called a virus-like particle (VLP) vaccine. Anti-viral vaccines have traditionally been prepared by using attenuated, or weakened, forms of the infectious virus. This type of vaccine involves complications in manufacturing.

These brand new virus-like particle (VLP) based vaccines including Merck`s Gardasil and GSK`s Cervarix are the first ever FDA approved VLP vaccines. No long term studies or studies on populations larger than the Gardasil clinical trial (20,541 women for up to 5 years) have ever been conducted on VLP technology or the specific inter-species genetic mixing this technology represents.

According to National Institute of Health (NIH) documents:

"The underlying technology for the vaccine originated in the laboratories of Drs. John Schiller and Douglas Lowy of the NIH National Cancer Institute. Drs. Schiller and Lowy commenced their research on the molecular biology of HPV nearly 20 years ago. Among their numerous findings, they discovered that the major outer coat protein of the HPV virus, called L1, could self assemble into non-infectious virus-like particles (VLPs) that closely resemble the native outer shell of the actual virus.

The principle behind the vaccine is that exposure to VLPs triggers the immune system to produce protective antibodies. If an individual is exposed to HPV after receiving the vaccine, the immune system already contains the antibodies necessary to prevent virus infection. The antibodies primarily function by preventing the virus from binding to the cell which is necessary in order for the virus to reproduce and thrive.

The catch is that for induction of HPV neutralizing antibodies the L1 must be in the same conformation as in the intact virus. Unlike some other viral vaccines, inactivated virus produced in cultured cells was not a viable option because the viruses could not be produced in sufficient quantities in vitro. Also, the inactivated virions would still contain the viral oncogenes, which would preclude use in healthy young people, the primary target population. (In other words, the vaccine would produce cancer, not prevent it.)

Schiller and Lowy demonstrated that large quantities of VLPs could be produced in insect cells (emphasis added) infected with L1 recombinant baculovirus (a genetically engineered protein grown in insect larvae). Critically, they also showed in animal models that the L1 VLPs were able to induce high titers of neutralizing antibodies, comparable to those induced by authentic virions. Furthermore, they and their colleagues demonstrated that L1 VLP vaccination could protect animals from experimental challenge with high dose virus of the corresponding animal papillomavirus (emphasis added) types and that human and animal papillomavirus (emphasis again added) L1 behaved similarly in the ability to assemble into VLP."

While individual papilloma virus types tend to be highly adapted to replication in a single animal species, researchers have already identified inter-species transmission of papilloma virus in rabbits and cattle. The evolution of papilloma viruses is slow compared to many other virus types. It is believed that papilloma viruses generally co-evolve with a particular species of host over many years.

The long term results of introducing into the human body genetically engineered, recombinant human, insect and animal DNA, along with human and animal strains of papillomavirus are unknown, untested and unproven, particularly when used as a vaccine, which effectively bypasses all of the body`s natural defenses against outside pathogens (skin, saliva, mucous, etc.)

The current deaths and maiming of young girls used as guinea pigs to test this new technology may be just the beginning. No one can predict what adverse consequences this newest inter-species gene mixing technology may cause. Remember we are dealing with the reproductive systems of an entire generation of young woman.

Furthermore, the two strains of HPV which the vaccine purportedly protects against account for only 70% of all cervical cancers, leaving at least 30% of these young girls with no protection against cervical cancer. To call this a cervical cancer vaccine is a tragic deception.

In addition, many health care experts have publicly predicted that cervical cancer deaths will increase sharply, with routine Pap tests foregone under a false sense of security that Gardasil has made them immune to cervical cancer (and not just the two strains of alleged cancer causing HPV for which the vaccine claims efficacy).

The fact that the vaccine is not effective in girls already exposed to the virus, yet parental supervision is mandated during the interview to determine if the recipient is sexually active, further undermines the ability to discern "qualified" candidates for this potentially dangerous, new, experimental, unproven, falsely promoted vaccine technology. Imagine a 16 year old girl who does not want to confess that she has been sexually active to a parent stating that she has not and then being administered this drug. According to a reported Merck document, if this young girl has previously been infected with HPV, she has just increased her risk of developing high grade pre-cancerous lesions of the cervix by 44.6%.

It was reported to the FDA as early as October 30, 2006 by letter. Sin Hang Lee, M.D., a practicing pathologist wrote to Dr. Steven I. Gutman, Director, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiological Health (CDRH), FDA, enclosing the manuscript of a scientific report titled "Human Papillomavirus Genotyping by DNA Sequencing-The Gold Standard HPV Test for Patient Care," which was submitted to a professional journal to be considered for publication. The purpose of the letter was to inform the FDA that a more sensitive and more specific device is being introduced for detection of HPV in clinical samples and for preparation of materials for HPV genotyping and to request advice and guidance from the agency for making this device available to hospital laboratories at the point of care . With this letter and manuscript, the FDA was informed of the need for a new generation of HPV testing based on new information available because:

1) A sensitive HPV detection device that can provide accurate genotyping information is needed for following patients with persistent infection that is now recognized to be the tumor promoter in cancer induction.

2) A PCR-based HPV detection device with provision for accurate HPV genotyping is more urgently needed now because vaccination with Gardasil of the women who are already sero-positive and PCR-positive for vaccine-relevant genotypes of HPV has been found to increase the risk of developing high-grade precancerous lesions by 44.6%, according to an FDA VRBPAC Background Document: Gardasil HPV Quadrivalent Vaccine . May 18, 2006 VRBPAC Meeting. www.fda.izov/ohrms/dockets/ac/06/br... [14].

Page 10 of the attached document included this statement:

The introduction of the type-specific Gardasil HPV vaccines among the sexually active women also requires genotype monitoring of the HPV infections before and after immunization to develop prevention strategy for the individual patients. Based on a `Background Document" submitted to the FDA by Merck & Co., Inc., injection of HPV vaccines into women who have concurrent vaccine-relevant HPV type infections may increase the risk, by 44 .6%, of developing high-grade precancerous lesions in the cervix. Therefore, it would be prudent to perform a sensitive HPV detection assay with accurate genotype determination on the patients to be vaccinated if prior HPV infection is suspected.

Recombinant DNA, genetically engineered proteins, inter-species gene mixing, questionable new vaccine technology, lack of long term safety and efficacy data, questionable pre-qualifications procedures and now, an extremely high prevalence of reported adverse side effects up to and including miscarriage and death.

This vaccine represents more than just bottom line profit for Merck. This is the first genetically modified drug unleashed across a broad swath of unsuspecting, formerly healthy Americans.

Unfortunately, the target they chose for this grand genetic experiment is the entire female population of mothers to be for all future generations. Can we really afford to allow this fraud and deception to continue?

Sources:

What Are the Key Statistics About Cervical Cancer? via American Cancer Society website
Human Papillomaviruses:Natural History and Virology, Elizabeth R. Unger Ph.D.,M.D. via FDA website
NIH Technology Licensed to Merck for HPV Vaccine via NIH Office of Technology Transfer website
FDA Press Release P06-77: FDA Licenses New Vaccine for Prevention of Cervical Cancer
and Other Diseases in Females Caused by Human Papillomavirus
Christensen ND (2005). "Cottontail rabbit papillomavirus (CRPV) model system to test antiviral and immunotherapeutic strategies". Antivir. Chem. Chemother. 16 (6): 355-62. PMID 16331841
Calleja-Macias IE, Villa LL, Prado JC, et al (2005). "Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16". J. Virol. 79(21):13630-40 doi:10.1128/JVI.79.21.13630-13640.2005. PMID 16227283
RECLASSIFICATION PETITION FOR Human Papillomavirus (HPV) DNA Nested Polymerase Chain Reaction (PCR) Detection via FDA website

Learn more: http://www.naturalnews.com/025613_cancer_HPV_vaccine.html#ixzz1aQA9SYyt

[LadyROOT]

http://www.naturalnews.com/032023_HPV_STDs.html


HPV - The bad-girl of STDs

Monday, April 11, 2011 by: Rosemary Mathis, Director of SANE VAX, INC.




(NaturalNews) Spinnaker Magazine, the official newspaper of the University of Northern Florida published an article on March 24, 2011 titled: Oral Sex now major concern in causes of throat cancer (http://www.unfspinnaker.com/).

Although the title is not disturbing, except for the fact that it perpetuates the marketing of fear to expand the use of Gardasil, the accompanying photo reveals the underlying message behind the vaccine campaign – only bad girls get HPV.

The accompanying photo – undoubtedly considered to be in poor taste by most consumers - depicts a 'perfect' woman wearing only a sexy red bra, her legs in air with a 'good American boy' going down on her and a statement on the back of shirt stating: HPV Grabs You By The Throat.

SANE Vax Inc. is appalled at the message the University of Florida Health Promotion Staff is conveying to women and men about the Human Papillomavirus and about women in general.

In fact, the article to comments made by Dr. John Oliver, a UNF adjunct psychology professor who teaches a class called Human Sexuality, "The key factor in determining a person's risk of HPV infection, is by the number of sexual partners the person has had in their lifetime. Oliver has researched the likelihood of STI contraction in the past and has found that by having three sex partners, a person has increased their likelihood of contraction by 30 times.

"By the time you've had your fifth partner, you've literally had sex with 400 people," Oliver said.

A couple of paragraphs later, Oliver then states: In a monogamous relationship....oral sex is healthy and acts as a "wonderful variation" for couples.

SANE Vax Inc. believes Oliver is preaching 'morality' based sexuality while re-enforcing a widely held belief that women's bodies are 'dirty' instead of promoting health.

Christine Northrup, MD, addresses this issue in her book titled, Women's Bodies Women's Wisdom, when she refers to the patriarchal myth that "women are socialized to think that their bodies are essentially 'dirty' – requiring constant surveillance for 'freshness' so that we do not offend....They are led to believe that they must control many aspects of their bodies and that their natural odors, shapes and processes such as menstruation are simply unacceptable."

Northrup also states: "This denigration of the female body has made many women either afraid of their bodies or else disgusted by them."(1)
SANE Vax, Inc. believes the re-enforcement of this patriarchal myth is the hidden agenda behind the government's HPV vaccine campaign – and reiterated by such blatant morality as depicted in the Spinnaker article. Women have been victimized by an HPV vaccine campaign that perpetuates fear about their morality; fear about an area of their bodies that is mysterious, dark and for some (especially adolescent girls) 'gross' and by a virus that they cannot see or that may not even pathologically manifest providing a perfect fear-based marketing strategy for Big Pharma.

In fact, the Spinnaker article does not contain any scientific data or references showing 90 percent of women who have contracted HPV pass it through their bodies in less than two years – without incident. Nor does it include that the National Cancer Institute has not made a causal link between HPV and cervical cancer.

"The finding of HPV viral DNA integrated in most cellular genomes of cervical carcinomas supports epidemiologic data linking this agent to cervical cancer however, direct causation has not been demonstrated."(2)

Instead, Ashley Ballard, coordinator of health education at Health Promotion, stated "many women do not know they have HPV, since some strains can have no visible symptoms or warts." Ballard also said it's important to realize HPV can be spread through skin-on-skin contact." This again is nothing short of fear-based morality.

The misinformation continues with this statement by Oliver.

"There are ways to help prevent HPV contraction. There are prescribed vaccines, such as Gardasil, that can be used to prevent certain strands of the HPV virus. Males between the ages of nine and 26 years old can use Gardasil, as well."

There is no way to prevent HPV contraction (unless of course Oliver is referring to abstinence until marriage...). According to the CDC over 25,000,000 women have been previously exposed to HPV.(3) Surely, not all of these are bad girls- now are they? According to the May 2006 FDA VRBPAC documents if a woman is previously exposed to HPV and is vaccinated with Gardasil her chances of getting cervical cancer increase by 44.6%; 32.5% with Cervarix.(4)

Gardasil does not prevent contraction of certain strands of the HPV virus. It renders HPV 16 and 18 ineffective – yet no one knows if other carcinogenic strands will mutate and take their place.

Nor does the article mention that cervical cancer is not due to a single infection, but multiple persistent infections ...meaning that it is the persistent infection, not the virus that determines cervical cancer risk.
The SANE Vax team has compiled a Global Concerns about HPV Vaccines Fact Sheet to counter the fear based morality HPV campaign instituted by Pharma, the government and now 'educational' institutions.

The fact sheet is posted at: http://sanevax.org/news-blog/2011/0...

Know the facts...the HPV vaccine issue is not about morality, abstinence and promiscuity – no matter what some ill-informed 'experts' would like adolescent teens, college age girls, and society to believe.

Sources:

1. Women's Bodies, Women's Wisdom, Creating Physical and Emotional Health and Healing, Northrup, Christine, MD, Random House Digital, Inc., 2010
2. Cervical Cancer Prevention, Health Professional Version published by the National Cancer Institute (NCI)
3. CDC extrapolation of population figures for that age group multiplied by the percentage of infected (potentially) http://www.cdc.gov/std/stats09/figu...
4. May 2006 VRBPAC Report -http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4222B3.pdf

[Cymberly]

This article is not about the HPV vaccine. But it made me start wondering about the real motivation behind the heavy handed push of the “vaccine”. Especially considering that the vaccine is potentially as dangerous as the problem it is suppose to help prevent.

If I remember my basic DNA studies correctly a female’s dna carries unique markers that makes it easier to identify family affiliation. This would mean that while the government might not have an individual person’s DNA on file, if they have the DNA of a female relative on file members of her family could be identified as being related to her and targeted for whatever reason, justified or unjustified. (For example DNA found on an envelope sent by an unknown person speaking out against the government. Even though the government would not have an exact match of the person sending the letters, the family of the person sending letters statements would be identifiable.)


Copied from:
http://www.israelnationalnews.com/News/News.aspx/148689#.TpSg1OxFpsg


Bin Laden Hit Kills Immunization Drive

A fraudulent vaccination drive mounted by the CIA in its quest to kill Osama Bin Laden has created blowback for real immunization efforts.


By Gavriel Queenann
First Publish: 10/11/2011

A fraudulent vaccination campaign orchestrated by the CIA in its quest to find and kill Al Qaeda arch-terrorist Osama Bin Laden has undercut Western-backed Immunization drives against polio and other diseases.
It has also put the Pakistani doctor who aided the CIA in carrying out the program in the Pakistani government’s crosshairs.

According to the Los Angeles Times, a Pakistani government commission investigating the targeted killing of Bin Laden by US forces in May recommended last week that treason charges be filed against Dr Shakeel Afridi.

Afridi, they say, helped carry out a fake vaccination effort designed to obtain DNA evidence from the Al Qaeda leader's sprawling compound in Abbottabad. If Afridi is charged and convicted, he could face the death penalty.

US officials have been seeking the doctor's release since his arrest in May by Pakistani intelligence agents and have defended the ruse, arguing extraordinary measures were needed to track down America’s most wanted – and elusive – terrorist.

But according to the Pakistan Tribune, the ruse not only compounded Pakistan's anger toward the US over the raid but also hampered efforts by Pakistani and Western aid organizations involved in real vaccination campaigns.

Fallout from the phony vaccination drive, Western aid organizations say, has also severely hampered their work and led to harassment by Pakistani intelligence agents suspicious of their affiliations.

"To live and work and get permission to do anything has become more difficult," said Pascal Cuttat, the departing head of the International Committee of the Red Cross delegation in Pakistan, told Reuters in July. "Everyone is struggling with the bureaucracy."